Submission of Manuscripts and Journal Emphases
Prior to submitting a manuscript to Development and Psychopathology, please read the journal’s guideline. Manuscripts are submitted through Development and Psychopathology’s submission website at https://mc.manuscriptcentral.com/dpp. Typically, the journal follows a masked review procedure in which the authors’ names are omitted from the submitted manuscript. Thus, authors’ names and affiliations should not be listed on the manuscript title page, and authors should endeavor to mask clearly identifying material in the manuscript to the extent feasible; Cambridge University Press editorial staff will assist with masking of author content before manuscript review.
Manuscript Review Process
The review process for most manuscripts involves two phases. First, the submission will be evaluated by one of the editors to ascertain whether the manuscript will be sent out for review. The manuscript will be sent out for further review if the submission is judged to constitute a potentially important contribution and consistent with the scope of Development and Psychopathology. This means that if an editor decides that the manuscript does not make a contribution and is unlikely to be accepted, the manuscript will be “desk rejected” and returned to the author(s) without further review or consideration. Should the submitting author disagree with this decision, there is an appeals process (see below). Second, assuming that the manuscript passes the first “desk reject” phase, the manuscript will then be sent out for external review. The primary focus of the review process and criterion for publication are whether the submission involves a substantive contribution that advances knowledge in developmental psychopathology, broadly conceived. With this two-phase process, it is our intent to accelerate the timeline for completing editorial review while maintaining robust, high-quality peer review.
Manuscripts will have a blind review, generally by two or more scholars. Every effort will be made to notify authors within 60 days of submission concerning the reviewers’ recommendations and comments. Development and Psychopathology has no page charges.
ORCID
We require all corresponding authors to identify themselves using ORCID when submitting a manuscript to this journal. ORCID provides a unique identifier for researchers and, through integration with key research workflows such as manuscript submission and grant applications, provides the following benefits:
- Discoverability: ORCID increases the discoverability of your publications, by enabling smarter publisher systems and by helping readers to reliably find work that you have authored.
- Convenience: As more organisations use ORCID, providing your iD or using it to register for services will automatically link activities to your ORCID record, and will enable you to share this information with other systems and platforms you use, saving you re-keying information multiple times.
- Keeping track: Your ORCID record is a neat place to store and (if you choose) share validated information about your research activities and affiliations.
See our ORCID FAQs for more information.
If you don’t already have an iD, you will need to create one if you decide to submit a manuscript to this journal. You can register for one directly from your user account on ScholarOne, or alternatively via https://ORCID.org/register.
If you already have an iD, please use this when submitting your manuscript, either by linking it to your ScholarOne account, or by supplying it during submission using the "Associate your existing ORCID iD" button.
ORCIDs can also be used if authors wish to communicate to readers up-to-date information about how they wish to be addressed or referred to (for example, they wish to include pronouns, additional titles, honorifics, name variations, etc.) alongside their published articles. We encourage authors to make use of the ORCID profile’s “Published Name” field for this purpose. This is entirely optional for authors who wish to communicate such information in connection with their article. Please note that this method is not currently recommended for author name changes: see Cambridge’s author name change policy if you want to change your name on an already published article. See our ORCID FAQs for more information.
Licence to publish
Before Cambridge can publish your manuscript, we need a signed licence to publish agreement. Under the agreement, certain rights are granted to the journal owner which allow publication of the article. The original ownership of the copyright in the article remains unchanged. For full details see the publishing agreement page.
Appealing Editorial Decisions
Authors may appeal a manuscript decision by emailing both the Action Editor who handled the manuscript and the two Co-Editors-in-Chief of the journal, cc’ing the Editorial Office. The email message must clearly state the case for why the decision should be changed. Appeals will only be considered if the authors: (a) identify factual errors made by the reviewers or Action Editor that had a major impact on the decision, or (b) can provide a substantiated claim of unfair treatment and/or bias in the review process. Appeals for any other reason will be denied without further consideration. Appeals that meet the identified criteria will be considered by the original Action Editor. Concerns may be escalated to the Co-Editors-in-Chief, but only after a decision on an appeal is rendered by the Action Editor.